D&C RED NO. 30

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
393.0 6.1 0 4 34.0 0 0.11
UNII
2S42T2808B
CAS
2379-74-0
SYNONYMS
  • 6-Chloro-2-(6-Chloro-4-Methyl-3-Oxobenzo(b)thien-2(3h)-Ylidene)-4-Methyl-Benzo(b)thiophen-3(2h)-One
  • Ci 73360
  • D&c Red No. 30
  • Red 30
  • Red 30 [inci]
  • Ci 73360 [inci]
  • Aka226 [inci]
  • Japan Red 226
  • Pigment Red 181
  • Vat Red 1
  • D&c Red No. 30 [ii]
  • Dc Red No. 30
  • D & C Red #30 Aluminum Lake [vandf]
  • D & C Red #30 [vandf]
  • D & C Red #30 Lake [vandf]
  • Aka226
  • Vat Red 1 [inci]
ZINC ID(s)
Availability
Present in 13 ZINC catalogs

Known Active Genes

This compound has been observed to have activity at 10μM or less against the following gene(s).
Name Description Classification
AMPC Class C beta-lactamase PDC-5 Unclassified / Unclassified

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Functions of D&c Red No. 30

Dye - Dye

Dosages

Route Formulation Per Unit Dose
Oral Capsule 0.1MG
Oral Suspension
Oral Tablet 2.21MG
Oral Tablet (immed./comp. Release), Uncoated, Chewable 1.46MG
Oral Tablet, Coated 1.16MG
Oral Tablet, Delayed Action
Oral Tablet, Extended Release 0.02MG
Oral Tablet, Film Coated 290MG
Oral Tablet 0.5MG
Oral Tablet 0.5MG

More Information

Usage Over Time

Comments